PERTUZUMAB ZUVOTOLIMOD
UNII H4LR6V1LWG

Substance Identification & Data

This profile provides standardized clinical and technical data for Pertuzumab Zuvotolimod, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H4LR6V1LWG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2500674-05-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H4LR6V1LWG
CAS Registry Number
2500674-05-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PERTUZUMAB ZUVOTOLIMOD
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11933
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pertuzumab Zuvotolimod. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PERTUZUMAB ZUVOTOLIMOD

Common Names & Synonyms

IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL M050 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M050 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((((3-(((2-AMINO-4-((DIPROPYLAMINO)CARBONYL)-3H-1-BENZAZEPIN-8-YL)CARBONYL)AMINO)-7,8-DIHYDRO-1,6-NAPHTHYRIDIN-6(5H)-YL)CARBONYL)OXY)METHYL)PHENYL)-L-ORNITHINAMIDE
PERTUZUMAB ZUVOTOLIMOD [INN]
SBT 6050 [WHO-DD]